CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD

Overview

CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD is an active pharmaceutical ingredient (API) supplier with 16 active FDA Type II Drug Master Files, covering BENIDIPINE HYDROCHLORIDE; BILASTINE; CALCIPOTRIOL ANHYDROUS; CALCIPOTRIOL MONOHYDRATE; CALCIUM LEVOFOLINATE HYDRATE; CRIZOTINIB.

API / Drug Master Files

CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD holds 16 active (16 total) FDA Type II Drug Master Files — identifying it as an active-substance / API supplier. Type II DMFs are filed with the FDA to support the use of an active pharmaceutical ingredient in drug applications.

• ISONIAZIDActive2026-02-24
• RUXOLITINIB PHOSPHATEActive2026-02-12
• BENIDIPINE HYDROCHLORIDEActive2025-12-24
• BILASTINEActive2025-08-11
• UPADACITINIB HEMIHYDRATEActive2025-06-05
• PERFLUOROHEXYLOCTANEActive2025-04-02
• ENZALUTAMIDEActive2025-04-01
• FINERENONEActive2025-03-17
• CALCIUM LEVOFOLINATE HYDRATEActive2025-01-24
• POSACONAZOLEActive2024-12-18
• FULVESTRANTActive2024-11-29
• NINTEDANIB ESILATEActive2024-10-31
• CRIZOTINIBActive2024-05-31
• RUXOLITINIB MESYLATEActive2024-03-29
• CALCIPOTRIOL ANHYDROUSActive2013-08-01

Showing 15 of 16 Drug Master Files.

FDA compliance signals

No FDA recalls, Warning Letters, or Form 483 observations are linked to CHONGQING HUAPONT SHENGCHEM PHARMACEUTICAL CO LTD in our records. PharmaTek screens the full directory against live FDA enforcement data.